Meniu
Asmeninė anketa Prisijungimas ir registracija
Atgal » » » 2020 » Lapkričio » 1

Giving the immune system a double boost against cancer

Giving the immune system a double boost against cancer

Cancer immunotherapies, which empower patients' immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions. But some cancers remain difficult to treat with immunotherapy, and expanding the impact of the approach is a high priority.

In the October 30 issue of the Proceedings of the National Academy of Sciences, a team led by Cold Spring Harbor Laboratory scientists Tobias Janowitz and Douglas Fearon together with Duncan Jodrell at the Cancer Research UK Cambridge Institute and Centre, University of Cambridge reports on a clinical trial of a drug that induces an integrated immune response in the tumors of patients with cancer types that do not usually respond to immunotherapy. The researchers hope the potential treatment might make such tumors more responsive to the class of drugs known as immune checkpoint inhibitors.

Checkpoint inhibitors release natural brakes on the immune system, freeing it to find and destroy cancer cells. But they generally have not been effective against cancer cells with low levels of genetic mutation. Janowitz said:

"Those tumors often do not seem to be visible to the immune system and do not seem to be unmasked by these therapies that are currently available. And we have reasons to believe that that is because they can engage an immune suppressive pathway that keeps most of the immune cells out of the cancer cell nest."

In this clinical trial, the research team interrupted that immunosuppressive pathway with a drug called plerixafor. The drug was administered continuously by I.V. for one week to 24 patients with either pancreatic cancer or colorectal cancer with a low tumor mutational burden. All patients had advanced disease, and biopsies were collected from metastatic tumors before and after treatment.

When the team analyzed those patient samples, they found that critical immune cells had infiltrated the tumors during the time patients received plerixafor, including a cell type known to summon and organize key players in the anti-cancer response. The finding was encouraging because the team detected changes that have also been observed in patients whose cancers responded well to checkpoint inhibitors.

Jodrell, who led the planning and patient recruitment for the clinical study, said, "I am delighted that the work of this multi-disciplinary team has translated important laboratory findings into patients, with the potential to make a difference in these hard-to-treat cancers." A clinical trial based on this study is about to start recruitment and will test the effects of combining plerixafor with an approved checkpoint inhibitor.

  • by Jennifer Michalowski, Cold Spring Harbor Laboratory
  • A highly specialized cell, the fibroblastic reticular cell, coordinates immune responses to cancer cells. In this image, a single fibroblastic reticular cell is identified, by staining it: the cell nucleus (blue), markers that identify fibroblast cells (red), and a molecule that attracts immune cells (green). Credit: CSHL, 2020

Turite savo nuomone, (už ar, prieš) pasidalinkite su mumis, palikite komentarą, prisijunkite, rašykite bloge, pasirinkdami kategoriją. Pasidalinkite savo receptais, sveikatos patarimais, nutikimais, susidūrėte su paranormaliais, anomališkais ir kitais nekasdieniškais reiškiniais. Galite išversti iš užsienio kalbos, talpinkite su nuoroda. Laukiame Jūsų straipsnių, naujienų, apžvalgų ar istorijų!

Įvertink šį straipsnį. Prieš tai pakomentuodami, arba parašykite patys! Norėdami tobulėti, suteikiame jums galimybę įvertinti skaitomą PARANORMAL turinį. Norite sužinoti daugiau, sutikite gauti naujienas arba pasidalinkite spausdami .
Niekas neišdrįso palikti komentaro.
Būkite pirmi, kurie pasidalins savo nuomonėmis su kitais.
avatar
TAIP PAT SKAITYKITE:
28.11.2020 laikas 15:06 INTERVIEW: Jeffrey Prather lays out how Trump, the DoD and Chris Miller DEFEAT the deep state traitors and save America
Jeffrey Prather (JeffreyPrather.com) is a former DIA intelligence analyst, former DEA investigations officer, served on the B Team of special operations forces, and is now an intelligence analyst working to save America from its enemies, both foreign and domestic....

Skaityti daugiau

28.11.2020 laikas 15:06 Liberals Heads Explode After CNN Video Surfaces Showing Path for Trump 2020 Win
Liberals went into meltdown mode on Black Friday after a resurfaced CNN video showed a possible path for President Trump to win the 2020 election.

Skaityti daugiau

28.11.2020 laikas 11:22 Virtinukai (ravioliai) su moliūgu ir rikota
Tenka pripažinti, kad mes su šeima nesame išprotėję dėl moliūgų. Bet kartas nuo karto užsinori pagaminti ir su šia daržoves. Galiu tik patikinti, kad moliūgas su rikota idealiai dera kartu, tad šie virtinukai (ravioliai) gaunasi nerealiai skanūs. Vien dėl jų verta į savo virtuvę įsileisti moliūgus d...

Skaityti daugiau

28.11.2020 laikas 11:22 UN Recruits 110,000 Social Media Influencers To Correct Online Covid Wrongthink
The United Nations has recruited more than 110,000 “social media influencers” to push “new social norms” and seek out and correct “wrong think” online.

Skaityti daugiau

28.11.2020 laikas 11:22 Pasvalietis Antanas: „Jaučiau nuoskaudą, kad mano tėviškę nuskriaudė, ūkį paėmė“

Su 89-uosius einančiu pasvaliečiu Antanu Jankevičiumi, daugiau nei pusšimtį metų buvusiu vairavimo mokytoju ir instruktoriumi, pašnekesį pradėjome nuo jo fotografijoje užfiksuoto Lėvens upės potvynio, kai buvo užlieta net Nepriklausomybės gatvė. Tai galėję būti maždaug prieš šešis dešimtmečius, d...

Skaityti daugiau